Search research articles
Contact Us
Filters
Showing results (71-80 of 105) with videos related to
Page
of 11
Sort By:
Oncology
|
October 20, 2024
Tissue and Imaging Biomarkers of Response to Neoadjuvant Nivolumab or Nivolumab plus Ipilimumab in Patients with Resectable Hepatocellular Carcinoma
Michael LaPelusa, Shadi Chamseddine, Hop Sanderson Tran Cao, et al.
Nature Communications
|
October 4, 2024
Multi-ancestry GWAS meta-analyses of lung cancer reveal susceptibility loci and elucidate smoking-independent genetic risk
Bryan R Gorman, Sun-Gou Ji, Michael Francis, et al.
Journal of the National Cancer Institute
|
February 8, 2024
Association of differential censoring with survival and suboptimal control arms among oncology clinical trials
Eric J Hsu, Timothy A Lin, Dor R Dabush, et al.
Transplantation and Cellular Therapy
|
September 19, 2025
Fludarabine Lymphodepletion Exposure is Associated with Toxicities after Idecabtagene-Vicleucel in Relapsed/Refractory Multiple Myeloma: Real-World Experience from the US Myeloma Immunotherapy Consortium
Karen Sweiss, Charlotte Wagner, Eric Anto, et al.
Leukemia
|
September 20, 2022
Impact of conditioning chemotherapy on lymphocyte kinetics and outcomes in LBCL patients treated with CAR T-cell therapy
Paolo Strati, Andrew P Jallouk, Ryan Sun, et al.
Breast Cancer Research and Treatment
|
April 15, 2023
A phase II study of neoadjuvant atezolizumab and nab-paclitaxel in patients with anthracycline-resistant early-stage triple-negative breast cancer
Clinton Yam, Elizabeth A Mittendorf, Haven R Garber, et al.
Blood
|
May 5, 2022
Risk assessment with low-pass whole-genome sequencing of cell-free DNA before CD19 CAR T-cell therapy for large B-cell lymphoma
Hua-Jay J Cherng, Ryan Sun, Bryant Sugg, et al.
Nature Communications
|
February 24, 2023
Multitrait genome-wide analyses identify new susceptibility loci and candidate drugs to primary sclerosing cholangitis
Younghun Han, Jinyoung Byun, Catherine Zhu, et al.
Cancers
|
March 10, 2022
Prognostic Impact of High Baseline Stromal Tumor-Infiltrating Lymphocytes in the Absence of Pathologic Complete Response in Early-Stage Triple-Negative Breast Cancer
Nour Abuhadra, Ryan Sun, Jennifer K Litton, et al.
Journal of Immunotherapy and Precision Oncology
|
June 6, 2022
Implementation of a Novel Web-Based Lesion Selection Tool to Improve Acquisition of Tumor Biopsy Specimens
Mingxuan Xu, Coya Tapia, Joud Hajjar, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 105) with videos related to
Sort By:
Page
of 11
Oncology
|
October 20, 2024
Tissue and Imaging Biomarkers of Response to Neoadjuvant Nivolumab or Nivolumab plus Ipilimumab in Patients with Resectable Hepatocellular Carcinoma
Michael LaPelusa, Shadi Chamseddine, Hop Sanderson Tran Cao, et al.
Nature Communications
|
October 4, 2024
Multi-ancestry GWAS meta-analyses of lung cancer reveal susceptibility loci and elucidate smoking-independent genetic risk
Bryan R Gorman, Sun-Gou Ji, Michael Francis, et al.
Journal of the National Cancer Institute
|
February 8, 2024
Association of differential censoring with survival and suboptimal control arms among oncology clinical trials
Eric J Hsu, Timothy A Lin, Dor R Dabush, et al.
Transplantation and Cellular Therapy
|
September 19, 2025
Fludarabine Lymphodepletion Exposure is Associated with Toxicities after Idecabtagene-Vicleucel in Relapsed/Refractory Multiple Myeloma: Real-World Experience from the US Myeloma Immunotherapy Consortium
Karen Sweiss, Charlotte Wagner, Eric Anto, et al.
Leukemia
|
September 20, 2022
Impact of conditioning chemotherapy on lymphocyte kinetics and outcomes in LBCL patients treated with CAR T-cell therapy
Paolo Strati, Andrew P Jallouk, Ryan Sun, et al.
Breast Cancer Research and Treatment
|
April 15, 2023
A phase II study of neoadjuvant atezolizumab and nab-paclitaxel in patients with anthracycline-resistant early-stage triple-negative breast cancer
Clinton Yam, Elizabeth A Mittendorf, Haven R Garber, et al.
Blood
|
May 5, 2022
Risk assessment with low-pass whole-genome sequencing of cell-free DNA before CD19 CAR T-cell therapy for large B-cell lymphoma
Hua-Jay J Cherng, Ryan Sun, Bryant Sugg, et al.
Nature Communications
|
February 24, 2023
Multitrait genome-wide analyses identify new susceptibility loci and candidate drugs to primary sclerosing cholangitis
Younghun Han, Jinyoung Byun, Catherine Zhu, et al.
Cancers
|
March 10, 2022
Prognostic Impact of High Baseline Stromal Tumor-Infiltrating Lymphocytes in the Absence of Pathologic Complete Response in Early-Stage Triple-Negative Breast Cancer
Nour Abuhadra, Ryan Sun, Jennifer K Litton, et al.
Journal of Immunotherapy and Precision Oncology
|
June 6, 2022
Implementation of a Novel Web-Based Lesion Selection Tool to Improve Acquisition of Tumor Biopsy Specimens
Mingxuan Xu, Coya Tapia, Joud Hajjar, et al.
Page
of 11